Single System Double Blinded Trial to Evaluate the Effect of Pre-operative Treatment With DigiFab to Prevent Post-operative Acute Kidney Injury (AKI) in Patients at High Risk for AKI Undergoing Cardiac Bypass Graft Surgery
Latest Information Update: 07 May 2024
At a glance
- Drugs Anti-digoxin polyclonal antibody (Primary)
- Indications Acute kidney injury
- Focus Therapeutic Use
Most Recent Events
- 30 Apr 2024 Status changed from recruiting to completed.
- 17 Jan 2024 Planned primary completion date changed from 1 Dec 2023 to 1 Jun 2024.
- 08 Mar 2023 Planned End Date changed from 1 Dec 2022 to 1 Dec 2024.